
The U.S. Securities and Exchange Commission (SEC) is suing a California biotech company after it made false statements about a Coronavirus blood testing kit. The company, Decision Diagnostics Corp (DECN), and its owner and CEO Keith Berman are accused of allegedly misleading investors throughout March and June by promoting a... Read More »